A carregar...
Do patients with reduced or excellent performance status derive the same clinical benefit from novel systemic cancer therapies? A systematic review and meta-analysis
BACKGROUND: Whether patients with excellent and reduced performance status (PS) derive different net clinical benefit from novel anticancer systemic therapies on clinical trials is unclear. MATERIALS AND METHODS: A systematic review was conducted of randomised controlled trials (RCTs) cited for drug...
Na minha lista:
| Publicado no: | ESMO Open |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5623318/ https://ncbi.nlm.nih.gov/pubmed/29209535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2017-000225 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|